Advertisement
Home »

A phase 2a, double-masked, randomized, vehicle-controlled trial of VVN001 in subjects with dry eye disease.

Jan 02, 2023

ABOUT THE EXPERTS

  • Joseph Tauber

    Tauber Eye Center, Kansas City, MO, USA.

    David Evans

    Total Eye Care PA, Memphis, TN, USA.

    Bruce Segal

    Segal Drug Trials, Inc, Delray Beach, FL, USA.

    Xiao-Yan Li

    VivaVision Biotech, Inc., Shanghai, China.

    Wang Shen

    VivaVision Biotech, Inc., Shanghai, China.

    Caroline Lu

    VivaVision Biotech, Inc., Shanghai, China.

    Gary D Novack

    PharmaLogic Development, Inc., San Rafael, CA, USA; University of California, Davis School of Medicine, USA. Electronic address: gary_novack@pharmalogic.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement